Lacticaseibacillus rhamnosus GG (LGG) stands as a prominent probiotic strain, recognized for its extensive applications in both food and health sectors. However, the potential for this strain has been hampered by the lack of precise and efficient genome editing techniques. This article introduces a refined workflow utilizing the endogenous type II-A CRISPR-Cas9 system for the functional engineering of LGG, aimed at enhancing its utility in various applications.
The Need for Genome Editing in LGG
The growing interest in probiotics has highlighted the necessity for advanced genetic tools that allow for the modification of microbial genomes. Traditional methods have often fallen short in terms of precision and efficiency, limiting the functional versatility of strains like LGG. The development of CRISPR-Cas9 technology has opened new avenues for genetic manipulation, enabling researchers to address these limitations effectively.
Establishing a CRISPR-Cas9 Workflow
In our approach, we have designed a comprehensive workflow that employs a plasmid interference assay alongside single-nucleotide substitutions. Through these methods, we identified the precise protospacer adjacent motif (PAM) requirement as 5′-NGAAA-3′. This critical information lays the groundwork for successful targeting of genomic loci.
Precision Engineering with Synthetic sgRNA
To facilitate accurate genome editing, we paired a synthetic single-guide RNA (sgRNA) cassette with homology-directed repair donors. This combination allows for the implementation of precise deletions and insertions across multiple loci within the LGG genome. The optimization of this method represents a significant advancement in genetic engineering capabilities for this probiotic strain.
Generating a β-Glucuronidase-Expressing Strain
Utilizing our refined genome editing technique, we successfully generated a β-glucuronidase (GUS)-expressing strain of LGG. This modified strain offers a robust mechanism for tracking within complex gut microbial communities, providing researchers with valuable insights into the behavior and interactions of probiotics in vivo.
Implications for Probiotic Engineering
The advancements presented in this study not only eliminate previous barriers to LGG engineering but also enhance the existing CRISPR toolkit for probiotics. By enabling precise genomic modifications, this work lays the foundation for creating next-generation probiotics that can be tailored for specific applications in food biotechnology and microbial therapeutics.
Future Directions and Broader Applications
The implications of this research extend beyond LGG. The strategies developed here can be applied to other probiotic strains, paving the way for a new era of functional probiotics. Future studies may explore the integration of additional functionalities into LGG or other strains, further enhancing their utility in health and nutrition.
Key Takeaways
- Lacticaseibacillus rhamnosus GG is a well-studied probiotic with untapped potential.
-
The established CRISPR-Cas9 workflow offers precise genome editing capabilities for LGG.
-
A GUS-expressing LGG strain was successfully constructed, allowing for effective tracking in microbial studies.
-
The methodologies developed can be applied to other probiotic strains, expanding the scope of genetic engineering in the field.
In conclusion, this study marks a significant advancement in the functional engineering of Lacticaseibacillus rhamnosus GG. By harnessing the power of the endogenous CRISPR-Cas9 system, we have opened new pathways for innovative probiotic designs, setting the stage for exciting developments in microbial health applications.
Read more → www.biorxiv.org